Wed, May 3, 2023
Tue, May 2, 2023
Mon, May 1, 2023

Matthew Kaplan Maintained (TGTX) at Strong Buy with Increased Target to $38 on, May 2nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-38-on-may-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Kaplan of Ladenburg Thalmann, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $26 to $38 on, May 2nd, 2023.

Matthew has made no other calls on TGTX in the last 4 months.



There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $34 on, Monday, May 1st, 2023
  • Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
  • Joshua Schimmer of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Tuesday, January 24th, 2023

Publication Contributing Sources